Genetics Generation Advancement Corp

Genetics Generation Advancement Corp maintains a strong liquidity position, with a current ratio of 3.62, indicating the company can easily cover its short-term liabilities with its short-term assets. The company's cash and equivalents amount to 129,986,000 TWD, which is a significant portion of its total assets, further supporting its liquidity. The debt-to-equity ratio is 0.04, suggesting a conservative capital structure with minimal reliance on debt financing.

In terms of profitability, the company's return on equity (ROE) is 3.1%, and its return on assets (ROA) is 2.4%. These figures are below the industry median for ROE and ROA, indicating that the company is not generating returns as efficiently as its peers. The net income of 14,219,000 TWD and operating income of 13,050,000 TWD reflect modest profitability, with a gross profit margin of 40.0%.

The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher risk if demand in its primary market fluctuates.

Looking at the growth trajectory, the company's revenue for the latest period is 166,874,000 TWD, with a gross profit of 66,757,000 TWD. While the company has a positive operating cash flow of 14,029,000 TWD, the capital expenditure of -281,000 TWD indicates minimal investment in new assets. Analyst estimates suggest a recent actual revenue of 266,868,000 TWD, which is higher than the reported revenue, indicating potential growth in the near term.

The risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and high cash reserves support the low liquidity risk rating. Additionally, the absence of dilution sources and the stable share count suggest that the company is not currently under pressure to issue new shares.

Recent events, as reflected in the financial data, show a negative EPS of -0.80 TWD, which may indicate challenges in profitability despite the positive net income. The discrepancy between the reported revenue and the analyst estimate suggests potential volatility or uncertainty in the company's financial performance.

Operating income surged 166.6% year-over-year, demonstrating significant operational leverage and improved profitability compared to the prior fiscal period.

Net income grew at a 26.5% compound annual growth rate over four years, indicating consistent long-term earnings expansion.

Low dilution, liquidity, and credit risk flags suggest a stable financial structure with minimal immediate balance sheet threats.

Free cash flow turned negative at -33.8 million TWD in FY0, reversing the positive trend seen in previous years.

Long-term debt increased substantially to 79.2 million TWD in FY0, rising from 40.3 million TWD in the prior year.

Revenue growth slowed to a 2.4% compound annual growth rate over four years, suggesting limited top-line expansion momentum.

Return on assets of 2.4% remains modest, indicating that asset utilization efficiency has not dramatically improved despite profit growth.

Debt-to-equity ratio of 0.04 is below the cohort median, but rising debt levels warrant monitoring for future leverage increases.

Revenue TWD 143.4M, −14,1% YoY; Operating income −47,0% YoY.

• ▍Revenue TWD 143.4M, −14,1% YoY
• ▍Operating income −47,0% YoY
• ▍Net income −46,2% YoY
• ▍Free cash flow −44,4% YoY
• ▍Net margin 5.3%

Revenue TWD 155.2M; Operating income TWD 622.0k.

• ▍Revenue TWD 155.2M
• ▍Operating income TWD 622.0k
• ▍Net margin 2.0%

Revenue TWD 603.1M, −8,9% YoY; Operating income −76,1% YoY.

• ▍Revenue TWD 603.1M, −8,9% YoY
• ▍Operating income −76,1% YoY
• ▍Net income −60,9% YoY
• ▍Free cash flow −199,2% YoY
• ▍Net margin 3.5%